Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1

Glucocorticoids such as dexamethasone are widely co-prescribed with cytotoxic therapy because of their proapoptotic effects in lymphoid cancer, reduction of inflammation and edema and additional benefits. Concerns about glucocorticoid-induced therapy resistance, enhanced metastasis and reduced survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Aleksandrowicz, Ewa, Schönsiegel, Frank, Gröner, Daniel, Bauer, Nathalie, Nwaeburu, Clifford C, Zhao, Zhefu, Gladkich, Jury, Hoppe-Tichy, Torsten, Yefenof, Eitan, Hackert, Thilo, Strobel, Oliver, Herr, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680577/
https://www.ncbi.nlm.nih.gov/pubmed/28981109
http://dx.doi.org/10.1038/cddis.2017.455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680577/
https://www.ncbi.nlm.nih.gov/pubmed/28981109
http://dx.doi.org/10.1038/cddis.2017.455

Ejemplares similares